Wang, D., Zhang, F. & Gao, G. CRISPR-based therapeutic genome enhancing: methods and in vivo supply by AAV vectors. Cell 181, 136–150 (2020).
Google Scholar
Wang, L. et al. Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations. Nat. Cell Biol. 23, 552–563 (2021).
Google Scholar
Wu, Z., Yang, H. & Colosi, P. Impact of genome measurement on AAV vector packaging. Mol Ther 18, 80–86 (2010).
Google Scholar
Colella, P., Ronzitti, G. & Mingozzi, F. Rising points in AAV-mediated in vivo gene remedy. Mol. Ther. Strategies Clin. Dev. 8, 87–104 (2018).
Google Scholar
Nguyen, G. N. et al. Lengthy-term AAV-mediated issue VIII expression in 9 hemophilia A canine: a ten 12 months follow-up evaluation on sturdiness, security and vector integration. Blood 134, 611–611 (2019).
Google Scholar
Chen, Q. et al. Focused supply of mRNA with polymer–lipid nanoparticles for in vivo base enhancing. ACS Nano 19, 7835–7850 (2025).
Google Scholar
Raguram, A., Banskota, S. & Liu, D. R. Therapeutic in vivo supply of gene enhancing brokers. Cell 185, 2806–2827 (2022).
Google Scholar
Wang, D., Tai, P. W. & Gao, G. Adeno-associated virus vector as a platform for gene remedy supply. Nat. Rev. Drug Discov. 18, 358–378 (2019).
Google Scholar
Banskota, S. et al. Engineered virus-like particles for environment friendly in vivo supply of therapeutic proteins. Cell 185, 250–265 (2022).
Google Scholar
Ling, S. et al. Customizable virus-like particles ship CRISPR–Cas9 ribonucleoprotein for efficient ocular neovascular and Huntington’s illness gene remedy. Nat. Nanotechnol. 20, 543–553 (2025).
Google Scholar
Hindi, S. M. et al. Enveloped viruses pseudotyped with mammalian myogenic cell fusogens goal skeletal muscle for gene supply. Cell 186, 2062–2077 (2023).
Google Scholar
Ling, S. et al. Lentiviral supply of co-packaged Cas9 mRNA and a Vegfa-targeting information RNA prevents moist age-related macular degeneration in mice. Nat. Biomed. Eng. 5, 144–156 (2021).
Google Scholar
Hamilton, J. R. et al. In vivo human T cell engineering with enveloped supply automobiles. Nat. Biotechnol. 42, 1684–1692 (2024).
Google Scholar
Kong, L. et al. Precision engineering for ocular gene remedy: molecular instruments, supply platforms, and illness purposes. Eye Discov. 2, 100040 (2026).
Google Scholar
Rees, H. A. & Liu, D. R. Base enhancing: precision chemistry on the genome and transcriptome of residing cells. Nat. Rev. Genet. 19, 770–788 (2018).
Google Scholar
Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome enhancing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824–844 (2020).
Google Scholar
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable enhancing of a goal base in genomic DNA with out double-stranded DNA cleavage. Nature 533, 420–424 (2016).
Google Scholar
Li, X. et al. Base enhancing with a Cpf1–cytidine deaminase fusion. Nat. Biotechnol. 36, 324–327 (2018).
Google Scholar
Wang, X. et al. Environment friendly base enhancing in methylated areas with a human APOBEC3A–Cas9 fusion. Nat. Biotechnol. 36, 946–949 (2018).
Google Scholar
Gaudelli, N. M. et al. Programmable base enhancing of A•T to G•C in genomic DNA with out DNA cleavage. Nature 551, 464–471 (2017).
Google Scholar
Xiao, Y. L., Wu, Y. & Tang, W. An adenine base editor variant expands context compatibility. Nat. Biotechnol. 42, 1442–1453 (2024).
Google Scholar
Chen, P. J. & Liu, D. R. Prime enhancing for exact and extremely versatile genome manipulation. Nat. Rev. Genet. 24, 161–177 (2023).
Google Scholar
Anzalone, A. V. et al. Search-and-replace genome enhancing with out double-strand breaks or donor DNA. Nature 576, 149–157 (2019).
Google Scholar
Kim, H. Ok. et al. Predicting the effectivity of prime enhancing information RNAs in human cells. Nat. Biotechnol. 39, 198–206 (2021).
Google Scholar
Yu, G. et al. Prediction of efficiencies for various prime enhancing programs in a number of cell sorts. Cell 186, 2256–2272 (2023).
Google Scholar
Li, X. et al. Extremely environment friendly prime enhancing by introducing same-sense mutations in pegRNA or stabilizing its construction. Nat. Commun. 13, 1669 (2022).
Google Scholar
Raguram, A., An, M., Chen, P. Z. & Liu, D. R. Directed evolution of engineered virus-like particles with improved manufacturing and transduction efficiencies. Nat. Biotechnol. 43, 1635–1647 (2025).
Google Scholar
An, M. et al. Engineered virus-like particles for transient supply of prime editor ribonucleoprotein complexes in vivo. Nat. Biotechnol. 42, 1526–1537 (2024).
Google Scholar
Geilenkeuser, J. et al. Engineered nucleocytosolic automobiles for loading of programmable editors. Cell 188, 2637–2655 (2025).
Google Scholar
Hwang, H.-Y. et al. Engineered Sdd7 cytosine base editors with enhanced specificity. Nat. Commun. 16, 5881 (2025).
Google Scholar
Han, W. et al. Design and utility of the transformer base editor in mammalian cells and mice. Nat. Protoc. 18, 3194–3228 (2023).
Google Scholar
Han, W. et al. Base enhancing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs. Cell Stem Cell 30, 1624–1639 (2023).
Google Scholar
Lai, Y. et al. Medical utility of base enhancing for treating β-thalassaemia. Nature 653, 923–932 (2026).
Google Scholar
Wu, Y., Xiao, Y.-L. & Tang, W. Excessive-precision cytosine base editors by evolving nucleic-acid-recognition hotspots in deaminase. Nat. Biotechnol. 44, 587–601 (2026).
Google Scholar
Mangeot, P. E. et al. Genome enhancing in major cells and in vivo utilizing viral-derived nanoblades loaded with Cas9–sgRNA ribonucleoproteins. Nat. Commun. 10, 45 (2019).
Google Scholar
Bao, X. et al. Focusing on proprotein convertase subtilisin/kexin kind 9 (PCSK9): from bench to bedside. Sign Transduct. Goal. Ther. 9, 13 (2024).
Google Scholar
Beard, W. A., Horton, J. Ok., Prasad, R. & Wilson, S. H. Eukaryotic base excision restore: new approaches shine mild on mechanism. Annu. Rev. Biochem. 88, 137–162 (2019).
Google Scholar
Serebrenik, A. A. et al. The deaminase APOBEC3B triggers the loss of life of cells missing uracil DNA glycosylase. Proc. Natl Acad. Sci. USA 116, 22158–22163 (2019).
Google Scholar
Komor, A. C. et al. Improved base excision restore inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with larger effectivity and product purity. Sci. Adv. 3, eaao4774 (2017).
Google Scholar
Wang, L. et al. Enhanced base enhancing by co-expression of free uracil DNA glycosylase inhibitor. Cell Res. 27, 1289–1292 (2017).
Google Scholar
Mol, C. D. et al. Crystal construction of human uracil-DNA glycosylase in advanced with a protein inhibitor: protein mimicry of DNA. Cell 82, 701–708 (1995).
Google Scholar
Yin, H. et al. Genome enhancing with Cas9 in grownup mice corrects a illness mutation and phenotype. Nat. Biotechnol. 32, 551–553 (2014).
Google Scholar
Yang, L. et al. Engineering APOBEC3A deaminase for extremely correct and environment friendly base enhancing. Nat. Chem. Biol. 20, 1176–1187 (2024).
Google Scholar
Lei, L. et al. APOBEC3 induces mutations throughout restore of CRISPR–Cas9-generated DNA breaks. Nat. Struct. Mol. Biol. 25, 45–52 (2018).
Google Scholar
Carter, R. J. & Parsons, J. L. Base excision restore, a pathway regulated by posttranslational modifications. Mol. Cell. Biol. 36, 1426–1437 (2016).
Google Scholar
Ma, H. et al. Multiplexed labeling of genomic loci with dCas9 and engineered sgRNAs utilizing CRISPRainbow. Nat. Biotechnol. 34, 528–530 (2016).
Google Scholar
Zalatan, J. G. et al. Engineering advanced artificial transcriptional packages with CRISPR RNA scaffolds. Cell 160, 339–350 (2015).
Google Scholar
Walton, R. T., Christie, Ok. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome concentrating on with near-PAMless engineered CRISPR–Cas9 variants. Science 368, 290–296 (2020).
Google Scholar
Neugebauer, M. E. et al. Evolution of an adenine base editor right into a small, environment friendly cytosine base editor with low off-target exercise. Nat. Biotechnol. 41, 673–685 (2023).
Google Scholar
Zhou, C. et al. Off-target RNA mutation induced by DNA base enhancing and its elimination by mutagenesis. Nature 571, 275–278 (2019).
Google Scholar
Chinsky, J. M. et al. Prognosis and therapy of tyrosinemia kind I: a US and Canadian consensus group assessment and suggestions. Genet. Med. 19, 1380–1395 (2017).
Google Scholar
González-Lamuño, D., Sánchez-Pintos, P., Andrade, F., Couce, M. L. & Aldámiz-Echevarría, L. Therapy adherence in tyrosinemia kind 1 sufferers. Orphanet J. Uncommon Dis. 16, 256 (2021).
Google Scholar
Tune, C. Q. & Xue, W. CRISPR–Cas-related applied sciences in fundamental and translational liver analysis. Nat. Rev. Gastroenterol. Hepatol. 15, 251–252 (2018).
Google Scholar
Meunier, L. & Larrey, D. Drug-induced liver harm: biomarkers, necessities, candidates, and validation. Entrance. Pharmacol. 10, 1482 (2019).
Google Scholar
Pérez-Gutiérrez, L. & Ferrara, N. Biology and therapeutic concentrating on of vascular endothelial progress issue A. Nat. Rev. Mol. Cell Biol. 24, 816–834 (2023).
Google Scholar
Lambert, V. et al. Laser-induced choroidal neovascularization mannequin to review age-related macular degeneration in mice. Nat. Protoc. 8, 2197–2211 (2013).
Google Scholar
Hu, S. et al. Nme2Cas9-mediated therapeutic enhancing in inhibiting angiogenesis after moist age-related macular degeneration onset. Clin. Transl. Med. 13, e1383 (2023).
Google Scholar
Guo, R. et al. Engineered IscB–ωRNA system with improved base enhancing effectivity for illness correction by way of single AAV supply in mice. Cell Rep. 43, 114973 (2024).
Google Scholar
Li, Z. et al. Engineering a transposon-associated TnpB–ωRNA system for environment friendly gene enhancing and phenotypic correction of a tyrosinaemia mouse mannequin. Nat. Commun. 15, 831 (2024).
Google Scholar
Kessler, P. D. et al. Gene supply to skeletal muscle leads to sustained expression and systemic supply of a therapeutic protein. Proc. Natl Acad. Sci. USA 93, 14082–14087 (1996).
Google Scholar
Hołubowicz, R. et al. Safer and environment friendly base enhancing and prime enhancing by way of ribonucleoproteins delivered by way of optimized lipid-nanoparticle formulations. Nat. Biomed. Eng. 9, 57–78 (2025).
Google Scholar
Yin, D. et al. Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers. Nat. Biomed. Eng. 9, 185–200 (2025).
Google Scholar
Strebinger, D. et al. Cell type-specific supply by modular envelope design. Nat. Commun. 14, 5141 (2023).
Google Scholar
Botchkarev, V. V. Jr. et al. In vivo gene enhancing of human hematopoietic stem and progenitor cells utilizing envelope-engineered virus-like particles. Nat. Biotechnol. (2025).
Renner, T. M., Tang, V. A., Burger, D. & Langlois, M.-A. Intact viral particle counts measured by stream virometry present perception into the infectivity and genome packaging effectivity of Moloney murine leukemia virus. J. Virol. 94, e01600-19 (2020).
Google Scholar
Bae, S., Park, J. & Kim, J.-S. Cas-OFFinder: a quick and versatile algorithm that searches for potential off-target websites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473–1475 (2014).
Google Scholar
Wang, D. et al. Optimized CRISPR information RNA design for 2 high-fidelity Cas9 variants by deep studying. Nat. Commun. 10, 4284 (2019).
Google Scholar
Musunuru, Ok. et al. In vivo CRISPR base enhancing of PCSK9 durably lowers ldl cholesterol in primates. Nature 593, 429–434 (2021).
Google Scholar
Wang, X. et al. Cas12a base editors induce environment friendly and particular enhancing with low DNA injury response. Cell Rep. 31, 107723 (2020).
Google Scholar
Leave a Reply